M3-Brigade Acquisition V Corp. $MBAV is BCK Capital Management LP’s 2nd Largest Position

BCK Capital Management LP raised its position in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) by 142.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 388,000 shares of the company’s stock after buying an additional 228,182 shares during the period. M3-Brigade Acquisition V makes up about 18.1% of BCK Capital Management LP’s holdings, making the stock its 2nd biggest holding. BCK Capital Management LP’s holdings in M3-Brigade Acquisition V were worth $4,124,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Prelude Capital Management LLC purchased a new position in M3-Brigade Acquisition V in the 3rd quarter valued at about $281,000. Sandia Investment Management LP purchased a new position in M3-Brigade Acquisition V in the 2nd quarter valued at about $334,000. Radcliffe Capital Management L.P. purchased a new position in M3-Brigade Acquisition V in the 3rd quarter valued at about $544,000. Susquehanna International Group LLP purchased a new position in M3-Brigade Acquisition V in the 3rd quarter valued at about $586,000. Finally, JPMorgan Chase & Co. purchased a new position in M3-Brigade Acquisition V in the 2nd quarter valued at about $900,000.

M3-Brigade Acquisition V Trading Down 0.1%

NASDAQ MBAV opened at $10.81 on Friday. M3-Brigade Acquisition V Corp. has a 12 month low of $10.48 and a 12 month high of $13.73. The company’s 50 day simple moving average is $10.82 and its 200 day simple moving average is $10.72.

M3-Brigade Acquisition V (NASDAQ:MBAV) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.05 EPS for the quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Wall Street Zen raised shares of M3-Brigade Acquisition V to a “sell” rating in a research report on Saturday, March 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of M3-Brigade Acquisition V in a research report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, M3-Brigade Acquisition V currently has an average rating of “Sell”.

M3-Brigade Acquisition V Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.